Competing Risk Analysis After Radical Prostatectomy for Clinically Nonmetastatic Prostate Adenocarcinoma According to Clinical Gleason Score and Patient Age
Author:
Affiliation:
1. From the Department of Urology and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference10 articles.
1. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators;Gooley;Stat Med,1999
2. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer;Albertsen;JAMA,1998
3. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis;Barry;Cancer,2001
4. Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome;Zincke;J Urol,1991
5. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation;Charlson;J Chron Dis,1987
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis;Heliyon;2024-02
2. Oncologic Outcomes of Radical Prostatectomy and High-Dose Intensity-Modulated Radiotherapy with Androgen-Deprivation Therapy for Relatively Young Patients with Unfavorable Intermediate-Risk Prostate Adenocarcinoma;Cancers;2021-03-25
3. Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study;Future Science OA;2021-03
4. External validation of a nomogram for the prediction of 10-year life expectancy in candidates for radical prostatectomy;World Journal of Urology;2019-03-04
5. Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy;Medicine;2018-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3